NCT06631612View on ClinicalTrials.gov

Daily Versus Alternate Day Regimen of Iron Supplementation in Children with Iron Deficiency Anemia

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

March 31, 2025

Conditions
Iron Deficiency Anemia Treatment
Interventions
DRUG

ferric hydroxide polymaltose complex

participants will receive oral iron supplementation according to body weight every other day

DRUG

ferric hydroxide polymaltose complex

participants will receive oral iron supplementation dose according to body weight daily

DRUG

Albendazole.

both arms will receive Albendazole 400mg once at the beginning f the study to be repeated after 1 week

Trial Locations (1)

Unknown

Ain Shams University Hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06631612 - Daily Versus Alternate Day Regimen of Iron Supplementation in Children with Iron Deficiency Anemia | Biotech Hunter | Biotech Hunter